What are the brand names and dosage forms for nortriptyline and gabapentin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Brand Names and Preparations for Nortriptyline and Gabapentin

Nortriptyline is available as an oral solution, typically prescribed at starting doses of 10-25 mg nightly, while gabapentin comes in tablet form (600 mg and 800 mg tablets) with starting doses of 100-300 mg nightly. 1, 2

Nortriptyline

Available Formulations

  • Oral solution (generic formulation) 1
  • No specific brand name is mentioned in the FDA labeling; nortriptyline is primarily available as a generic medication

Dosing Preparations

According to FDA labeling, nortriptyline hydrochloride oral solution is the standard preparation 1. The medication is typically initiated at:

  • Starting dose: 10-25 mg nightly for pain management 3
  • Therapeutic range: 50-150 mg nightly for neuropathic pain 3
  • Plasma concentration monitoring: Recommended when doses exceed 100 mg daily, with optimal plasma levels of 50-150 ng/mL 1

Important Prescribing Considerations

  • Start low in elderly patients: 30-50 mg/day in divided doses 1
  • Titration schedule: Increase every 3-5 days as tolerated 3
  • Maximum recommended dose: 150 mg per day; doses above this are not recommended 1

Gabapentin

Available Formulations

Gabapentin tablets are available in two strengths 2:

  • 600 mg tablets: White film-coated, modified capsule-shaped, biconvex tablets
  • 800 mg tablets: White film-coated, modified capsule-shaped, biconvex tablets

Dosing Preparations

The standard titration schedule for neuropathic pain 3, 4:

  • Starting dose: 100-300 mg at bedtime or 100-300 mg three times daily
  • Titration: Increase by 100-300 mg every 1-7 days as tolerated
  • Target therapeutic range: 900-3600 mg daily in divided doses (2-3 times daily)
  • Dose increments: 50-100% every few days

Critical Dosing Adjustments

  • Renal insufficiency: Dose adjustment required 3, 4
  • Elderly or medically frail: Slower titration recommended 3
  • Adequate trial duration: May require 2 months or more to assess full efficacy 4

Comparative Tolerability

Nortriptyline is better tolerated than tertiary amine tricyclics (amitriptyline, imipramine) due to fewer anticholinergic effects 3. Common side effects include:

  • Sedation
  • Dry mouth
  • Urinary hesitancy (less than with amitriptyline)

Gabapentin demonstrates excellent tolerability with primarily dose-dependent side effects 5. The medication has:

  • No significant drug interactions with most common medications 2
  • Linear dose-response relationship
  • Minimal systemic adverse effects

Clinical Efficacy Context

Recent evidence suggests combination therapy with nortriptyline and gabapentin provides superior pain relief compared to either agent alone 6. In a randomized controlled crossover trial, combination treatment reduced pain scores to 2.3 (on a 0-10 scale) compared to 3.2 for gabapentin alone and 2.9 for nortriptyline alone, with statistically significant differences (p=0.001 and p=0.02 respectively).

Practical Prescribing Algorithm

  1. Initiate monotherapy with either agent based on patient comorbidities (nortriptyline if insomnia present; gabapentin if anticholinergic effects are concerning)
  2. Titrate to maximum tolerated dose over 4-8 weeks
  3. If partial response, consider adding the second agent rather than switching
  4. Monitor plasma levels for nortriptyline if doses exceed 100 mg daily 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.